We are live on ! Find out more
OCRX

Ocera Therapeutics, Inc.
OCRX

Delisted

OCRX was delisted on the 8th of December, 2017.

Back to rankings

Fund managers haven’t disclosed any holdings of OCRX yet.

OCRX Hedge Fund Activity: Q4 2017 in Review

0 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Ocera Therapeutics, Inc. (OCRX) for Q4 2017, worth a combined $0 — down 100% from $5.17M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of OCRX and 0 opened new positions — a net loss of 21 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Perceptive Advisors, exiting entirely with an estimated $2.32M sold.

  • 0 institutional investors held Ocera Therapeutics, Inc. (OCRX) as of Q4 2017, down from 21 in Q3 2017.
  • Funds reported $0 of Ocera Therapeutics, Inc. stock for Q4 2017, down 100% quarter-over-quarter.
  • 0 funds opened new Ocera Therapeutics, Inc. positions in Q4 2017 and 21 closed out, a net change of -21 holders.
  • The largest Ocera Therapeutics, Inc. seller in Q4 2017 was Perceptive Advisors, an estimated $2.32M sold.

Based on aggregated 13F filings for Q4 2017.